点击次数：

发布时间：2019-03-12

论文类型：期刊论文

发表时间：2018-11-14

发表刊物：ACS APPLIED MATERIALS & INTERFACES

收录刊物：Scopus、SCIE、PubMed

卷号：10

期号：45

页面范围：38659-38662

ISSN号：1944-8244

关键字：iRGD; photothermal therapy; combinatorial therapy; immunotherapy; primary and metastatic tumors

摘要：Nanomedicine is at the forefront of targeted drug delivery for cancer therapy. An improved combinatorial approach is highlighted for breast cancer treatment by Hu et al. in this issue of ACS Applied Materials and Interfaces. The authors demonstrated that, by combining multistage-responsive nanoparticles carrying a therapeutic drug, doxorubicin, a photothermal agent, indocyanine green, and a nitric oxide donor with photothermal therapy and intravenous injection of a tumor-homing iRGD peptide, one could achieve efficient therapeutics distribution deep inside the tumor and nearly eradicate primary tumor growth. An in-depth understanding of this approach in combination with other strategies such as the use of immunomodulators would facilitate treating metastasis in distant organs, and clinical translation of this platform, benefiting cancer patients by providing long-lasting efficacy.